Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats

References

• Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al.. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2001;123(4):e18–209.
   Google Scholar
• Rouhl RP, van Oostenbrugge RJ, Damoiseaux J, Tervaert JW, Lodder J. Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke. 2008;39(7):2158–65.
   PubMed Web of Science ®Google Scholar
• Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al.. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001; 32(11):2682–8.
   PubMed Web of Science ®Google Scholar
• Newcomb JD, Ajmo CT, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006;15(3):213–23.
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57(6):874–82.
   PubMed Web of Science ®Google Scholar
• Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al.. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109(5):1801–9.
   PubMed Web of Science ®Google Scholar
• Shen LH, Li Y, Chen J, Cui Y, Zhang C, Kapke A, et al.. One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke. 2007;38(7):2150–6.
   PubMed Web of Science ®Google Scholar
• Moubarik C, Guillet B, Youssef B, Codaccioni JL, Piercecchi MD, Sabatier F, et al.. Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke. Stem Cell Rev. 2011;7(1):208–20.
   PubMed Web of Science ®Google Scholar
• Chu K, Park KI, Lee ST, Jung KH, Ko SY, Kang L, et al.. Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia. Neurosci Res. 2005;53(4):384–90.
   PubMed Web of Science ®Google Scholar
• Hanabusa K, Nagaya N, Iwase T, Itoh T, Murakami S, Shimizu Y, et al.. Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats. Stroke. 2005;36(4):853–8.
   PubMed Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91.
   PubMed Web of Science ®Google Scholar
• Codaccioni JL, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet BA. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology. (2009;110(6):1271–8.
   PubMed Web of Science ®Google Scholar
• Cuccuini W, Poitevin S, Poitevin G, Dignat-George F, Cornillet-Lefebvre P, Sabatier F, et al.. Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non coagulant properties in vitro. J Thromb Haemost. 2010;8(9):2042–52.
   PubMed Web of Science ®Google Scholar
• Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24(1):117–21.
   PubMed Web of Science ®Google Scholar
• Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, et al.. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104(9):2752–60.
   PubMed Web of Science ®Google Scholar
• Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al.. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2004;18(5):683–92.
   Google Scholar
• Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, et al.. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;39(5):1569–74.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang F, Zhang Y, Gao X, Li C, Yang N, et al.. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair. Transpl Int. 2007;20(2):174–83.
   PubMed Web of Science ®Google Scholar
• Burns TC, Steinberg GK. Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther. 2011;11(4):447–61.
   PubMed Web of Science ®Google Scholar
• Jerndal M, Forsberg K, Sena ES, Macleod MR, O'Collins VE, Linden T, et al.. A systematic review and meta analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab. 2010;30(5):961–8.
   PubMed Web of Science ®Google Scholar
• Esneault E, Pacary E, Eddi D, Freret T, Tixier E, Toutain J, et al.. Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2008;28(9):1552–63.
   PubMed Web of Science ®Google Scholar
• Velly L, Pellegrini L, Guillet B, Bruder N, Pisano P. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther. 2010;128(3):445–59.
   PubMed Web of Science ®Google Scholar
• Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, et al.. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther. 2005;11(1):96–104.
   PubMed Web of Science ®Google Scholar
• Lladó J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci. 2004;27(3):322–31.
   PubMed Web of Science ®Google Scholar
• Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, et al.. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med. 2003;198(6):971–5.
   PubMed Web of Science ®Google Scholar
• Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD, et al.. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005;14(5):595–604.
   PubMed Web of Science ®Google Scholar
• Lee ST, Chu K, Jung KH, Kim SJ, Kim DH, Kang KM, et al.. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain. 2008;131(Pt 3):616–29.
   PubMedGoogle Scholar
• Belayev L, Khoutorova L, Zhao W, Vigdorchik A, Belayev A, Busto R, et al.. Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats. Stroke. 2005;36(5):1071–6.
   PubMedGoogle Scholar
• Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76(1):105–16.
   PubMed Web of Science ®Google Scholar
• Byts N, Samoylenko A, Fasshauer T, Ivanisevic M, Hennighausen L, Ehrenreich H, et al.. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death Differ. 2008;15(4):783–92.
   PubMed Web of Science ®Google Scholar
• Minnerup J, Wersching H, Brokinkel B, Dziewas R, Heuschmann PU, Nabavi DG, et al.. The impact of lesion location and lesion size on poststroke infection frequency. J Neurol Neurosurg Psychiatry. 2010;81(2):198–202.
   PubMed Web of Science ®Google Scholar
• Stein A, Knödler M, Makowski M, Kühnel S, Nekolla S, Keithahn A, et al.. Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction. BMC Cardiovasc Disord. 2010;17(10):43.
   Google Scholar
• Kim YJ, Jung YW. Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brain. Anat Cell Biol. 2010;43(2):140–9.
   PubMedGoogle Scholar
• Yip HK, Tsai TH, Lin HS, Chen SF, Sun CK, Leu S, et al.. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit Care. 2011;15(1):R40.
   PubMedGoogle Scholar
• Byts N, Sirén AL. Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med. 2009;21(1):4.
   Google Scholar
• Wang L, Chopp M, Gregg SR, Zhang RL, Teng H, Jiang A, et al.. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab. 2008;28(7):1361–8.
   PubMed Web of Science ®Google Scholar
• Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, Gao J, et al.. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci. 2006;26(4):1269–74.
   PubMed Web of Science ®Google Scholar
• Viviani B, Bartesaghi S, Corsini E, Villa P, Ghezzi P, Garau A, et al.. Erythropoietin protects primary hippocampal neurons increasing the expression of brain derived neurotrophic factor. J Neurochem. 2005;93(2):412–21.
   PubMed Web of Science ®Google Scholar
• Ohab JJ, Carmichael ST. Poststroke neurogenesis: emerging principles of migration and localization of immature neurons. Neuroscientist. 2008;14(4):369–80.
   PubMed Web of Science ®Google Scholar